Algirdas Griškevičius, the head of the lab’s clinical research, told BNS that the level of readiness will be established after the testing.
The deadly Ebola virus has claimed more than 4,000 lives across the globe, with major outbreaks reported in Western African countries of Guinea, Liberia and Sierra Leone.
Be the first to comment